Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Inogen (INGN)
NASDAQ:INGN
Holding INGN?
Track your performance easily
INGN Stock Chart & Stats
Day’s Range― - ―
52-Week Range$5.08 - $13.33
Previous CloseN/A
Volume110.44K
Average Volume (3M)175.44K
Market Cap
$250.57M
Enterprise Value$126.28M
Total Cash (Recent Filing)$113.88M
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta2.07
Next Earnings
Feb 25, 2025EPS Estimate
-0.61Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.25
Shares Outstanding23,818,413
10 Day Avg. Volume195,045
30 Day Avg. Volume175,445
Standard Deviation0.17
R-Squared0.10
Alpha-0.03
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.76
Price to Cash Flow (P/CF)9.00
P/FCF Ratio11.80
Enterprise Value/Market Cap0.50
Enterprise Value/Revenue0.38
Enterprise Value/Gross Profit1.00
Enterprise Value/Ebitda-3.09
Forecast
1Y Price Target
$10.00Price Target Upside-4.49% Downside
Rating ConsensusModerate Sell
Number of Analyst Covering3
Inogen News
PremiumCompany Announcements
Inogen Expands U.S. Market with FDA Clearance
PremiumCompany Announcements
Inogen, Inc. Reports Third Quarter 2024 Financial Results
Bulls Say, Bears Say
Bulls Say
Business ExpansionB2B sales exceeded expectations due to new customer wins and increased business from existing customers.
Financial PerformanceNew management's streak of topline beats has reached four consecutive quarters.
Revenue GrowthINGN preannounced 4Q24 revenue of $79.0-80.0M, above consensus of $74.0M.
Bears Say
Direct-to-Consumer BusinessThe company continues to work to stabilize its DTC business.
ProfitabilityThere is still a long way to go for INGN to reach sustained profitability.
Sales PerformanceDTC sales fell short of expectations due to a decline in sales rep headcount.
---
Ownership Overview
1.49% Insiders
21.46% Mutual Funds
0.31% Other Institutional Investors
65.72% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
INGN FAQ
What was Inogen’s price range in the past 12 months?
Inogen lowest stock price was $5.08 and its highest was $13.33 in the past 12 months.
What is Inogen’s market cap?
Inogen’s market cap is $250.57M.
When is Inogen’s upcoming earnings report date?
Inogen’s upcoming earnings report date is Feb 25, 2025 which is in 36 days.
How were Inogen’s earnings last quarter?
Inogen released its earnings results on Nov 07, 2024. The company reported -$0.25 earnings per share for the quarter, beating the consensus estimate of -$0.496 by $0.246.
Is Inogen overvalued?
According to Wall Street analysts Inogen’s price is currently Overvalued.
Does Inogen pay dividends?
Inogen does not currently pay dividends.
What is Inogen’s EPS estimate?
Inogen’s EPS estimate is -0.61.
How many shares outstanding does Inogen have?
Inogen has 23,818,413 shares outstanding.
What happened to Inogen’s price movement after its last earnings report?
Inogen reported an EPS of -$0.25 in its last earnings report, beating expectations of -$0.496. Following the earnings report the stock price went up 17.23%.
Which hedge fund is a major shareholder of Inogen?
Currently, no hedge funds are holding shares in INGN
---
Inogen Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Sell
Average Price Target:
$10.00 (-4.49% Downside)
$10.00 (-4.49% Downside)
Blogger Sentiment
Bullish
INGN Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 32.5K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Negative
Last 7 Days ▼ 1.7%
Last 30 Days ▼ 0.1%
Last 30 Days ▼ 0.1%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
94.97%
12-Months-Change
Fundamentals
Return on Equity
-25.33%
Trailing 12-Months
Asset Growth
-10.92%
Trailing 12-Months
Company Description
Inogen
Inogen, Inc . engages in the development, manufacture, and marketing of portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its products consists of Inogen One G4 system, Inogen One G3 system, Inogen One G2 system, and Inogen at Home. The company was founded by Alison Perry, Alison Bauerlein, Brenton Taylor and Byron Myers on November 27, 2001 and is headquartered in Goleta, CA.
---
INGN Company Deck
---
INGN Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a balanced view with significant revenue growth, especially in business-to-business channels, and positive cash flow as key highlights. However, challenges remain in the direct-to-consumer and rental segments, with increasing operating expenses and anticipated adjusted EBITDA losses being notable lowlights.Read More>---
INGN Stock 12 Month Forecast
Average Price Target
$10.00
▼(-4.49% Downside)
Technical Analysis
Best Analysts Covering INGN
1 Year
1 Year Success Rate
12/18 ratings generated profit
1 Year Average Return
+22.63%
reiterated a sell rating 2 months ago
Copying Robbie Marcus's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +22.63% per trade.
---